Reflecting a steep deterioration of market conditions in the global hearing care industry in the final weeks of FY 2019/20, Sonova updates its outlook. In local currencies, the Group now expects sales for the financial year to grow by around 8% (previous guidance: 9%-11%) and a rise in adjusted EBITA below the previous guidance. While the growth in adjusted EBITA was well in line with the updated guidance until the start of the pandemic, an accurate estimate for FY 2019/20 is not possible at this time due to the rapidly changing environment.